PCM
PRCT icon

Pinz Capital Management’s Procept Biorobotics PRCT Stock Holding History

Pinz Capital Management’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-16,900
Closed -$645K – 452
2021
Q3 		$645K Buy
+16,900
New +$649K 0.29% 66

Other funds holding PRCT

CI
CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Pinz Capital Management's PRCT Position: Q4 2021 in Review

Pinz Capital Management sold out of Procept Biorobotics (PRCT) in Q4 2021, closing a stake of 16,900 shares — an estimated $645K sold.

Pinz Capital Management first reported a position in PRCT in Q3 2021 and held it in 1 quarter. The position peaked at $645K in Q3 2021. 60 funds tracked by Wall St. Rank hold PRCT as of Q4 2021.

  • Pinz Capital Management reported no remaining Procept Biorobotics position as of Q4 2021 after selling out during the quarter.
  • Pinz Capital Management sold 16,900 Procept Biorobotics shares in Q4 2021, an estimated $645K.
  • Pinz Capital Management first reported a position in Procept Biorobotics in Q3 2021 and held it in 1 quarter.
  • Pinz Capital Management's Procept Biorobotics position peaked at $645K in Q3 2021.
  • 60 funds tracked by Wall St. Rank held Procept Biorobotics as of Q4 2021.

Based on Pinz Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.